JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.92B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.54B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.2B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
iShares MBS ETF
MBB
|
+$780M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.34B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.3B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.6B |
| 4 |
Texas Instruments
TXN
|
+$1.53B |
| 5 |
Tesla
TSLA
|
+$1.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.53% |
| 2 | Financials | 10.45% |
| 3 | Consumer Discretionary | 10.06% |
| 4 | Healthcare | 9.81% |
| 5 | Industrials | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Southern First Bancshares
SFST
$607M
| $770K | ﹤0.01% |
21,780
+14,943
| +219% | +$460K |
|
|
CHMI
3952
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $767K | ﹤0.01% |
83,880
+28,367
| +51% | +$264K |
|
3953
Lantheus
LNTH
$6.57B
| $766K | ﹤0.01% |
56,814
-29,197
| -34% | -$382K |
|
3954
Primis Financial Corp
FRST
$411M
| $765K | ﹤0.01% |
63,210
+47,730
| +308% | +$517K |
|
3955
Intrepid Potash
IPI
$490M
| $764K | ﹤0.01% |
31,633
+21,506
| +212% | +$268K |
|
3956
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.41B
| $764K | ﹤0.01% |
22,607
+11
| +0% | +$343 |
|
|
CBIO
3957
Crescent Biopharma
CBIO
$610M
| $763K | ﹤0.01% |
2,028
+1,282
| +172% | +$449K |
|
3958
Peoples Financial Services
PFIS
$714M
| $763K | ﹤0.01% |
20,741
+14,585
| +237% | +$553K |
|
3959
PUT
Banco Santander
SAN
$211B
| $763K | ﹤0.01% |
+250,000
| New | +$633K |
|
3960
Greenlight Captial
GLRE
$505M
| $762K | ﹤0.01% |
104,220
+68,174
| +189% | +$505K |
|
3961
Pulse Biosciences
PLSE
$3.09B
| $760K | ﹤0.01% |
31,836
+26,729
| +523% | +$425K |
|
|
GATO
3962
DELISTED
Gatos Silver, Inc.
GATO
| $760K | ﹤0.01% |
+58,330
| New | +$447K |
|
3963
Stoneridge
SRI
$197M
| $759K | ﹤0.01% |
25,094
+15,027
| +149% | +$389K |
|
3964
Franklin Covey
FC
$234M
| $757K | ﹤0.01% |
33,975
+25,554
| +303% | +$531K |
|
3965
Cogent Biosciences
COGT
$6.76B
| $755K | ﹤0.01% |
+67,214
| New | +$739K |
|
|
SMMF
3966
DELISTED
Summit Financial Group, Inc.
SMMF
| $755K | ﹤0.01% |
34,229
+22,941
| +203% | +$452K |
|
|
ZYNE
3967
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $755K | ﹤0.01% |
229,001
+16,919
| +8% | +$64.2K |
|
3968
Genie Energy
GNE
$380M
| $752K | ﹤0.01% |
104,313
+19,888
| +24% | +$168K |
|
3969
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $751K | ﹤0.01% |
10,655
-1,113
| -9% | -$73.9K |
|
|
VOXX
3970
DELISTED
VOXX International Corporation Class A
VOXX
| $749K | ﹤0.01% |
58,711
+51,319
| +694% | +$600K |
|
|
CASA
3971
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $746K | ﹤0.01% |
120,860
+79,860
| +195% | +$422K |
|
|
STXB
3972
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $746K | ﹤0.01% |
44,379
+28,479
| +179% | +$427K |
|
|
FNHC
3973
DELISTED
FedNat Holding Company Common Stock
FNHC
| $744K | ﹤0.01% |
125,666
-196,069
| -61% | -$1.12M |
|
|
INBX
3974
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $742K | ﹤0.01% |
+22,484
| New | +$598K |
|
3975
Clearfield
CLFD
$395M
| $741K | ﹤0.01% |
29,970
+22,671
| +311% | +$531K |
|
Similar funds
JP Morgan Chase's Q4 2020 Portfolio in Review
As of Q4 2020, JP Morgan Chase held 6,220 positions worth $681B, up 14% from $595B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2020 filing shows 531 new, 2,858 increased, 1,755 reduced and 504 closed positions. Its largest new stake was Apartment Income REIT Corp.: 5,811,161 shares worth $223M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2020 buy was Apartment Income REIT Corp.: 5,811,161 shares worth $223M.
- JP Morgan Chase added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $3.92B increase.
- JP Morgan Chase's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.34B.
- JP Morgan Chase fully exited Bank of America Series L in Q4 2020, selling an estimated $117M.
- JP Morgan Chase's ten largest holdings make up 16% of its $681B portfolio in Q4 2020.
- JP Morgan Chase opened 531 new positions and closed 504 in Q4 2020.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $681B.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.